Pascal Soriot

PublicAcquisition

target

Zs Pharma

bidder

Astrazeneca

£1,761m

6 dealmakers

Japan

PrivateAcquisitionJoint Venture

target

Daiichi Sankyo (trastuzumab Deruxtecan)

bidder

Astrazeneca

£5,258m

11 dealmakers

MajorityPublicAcquisitionCross Border

target

Alexion Pharmaceuticals

bidder

Astrazeneca

£29,441m

63 dealmakers

United Kingdom

AcquisitionCross BorderMajorityPrivate

target

CRESTOR

bidder

GRUNENTHAL

£262m

12 dealmakers

Cross BorderAcquisitionMajorityPrivate

target

Caelum Biosciences

bidder

Astrazeneca

£257m

10 dealmakers

United Kingdom

Cross BorderMajorityPrivateAcquisition

target

Astrazeneca (eklira And Duaklir)

bidder

Covis Pharma

£197m

13 dealmakers

United Kingdom

De-SPACDomesticPrivateMajorityReverse TakeoverPrivate EquityAcquisitionMerger

target

BENEVOLENTAI

bidder

Temasek Holdings

£1,282m

71 dealmakers

Cross BorderPrivate EquityAcquisitionVenture CapitalPrivateMinority

target

NUPROBE

bidder

Astrazeneca

£39m

7 dealmakers

MajorityAcquisitionPrivateCross Border

target

TENEOTWO

bidder

Astrazeneca

£1,048m

14 dealmakers

Netherlands

Private EquityCross BorderAcquisitionMajorityPrivate

target

Neogene Therapeutics

bidder

Astrazeneca

£264m

60 dealmakers

MajorityAcquisitionCross BorderPublicPrivate Equity

target

Cincor Pharma

bidder

Astrazeneca

£1,487m

79 dealmakers

AcquisitionMajorityPrivateDomestic

target

Pfizer (preclinical Gene Therapy Programs)

bidder

Alexion Pharmaceuticals

£779m

14 dealmakers

Canada